Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Ying Qing, Lei Dong, Lei Gao, et al.
Molecular Cell (2021) Vol. 81, Iss. 5, pp. 922-939.e9
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
FTO mediates LINE1 m 6 A demethylation and chromatin regulation in mESCs and mouse development
Jiangbo Wei, Xianbin Yu, Lei Yang, et al.
Science (2022) Vol. 376, Iss. 6596, pp. 968-973
Open Access | Times Cited: 156
The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia
Hengyou Weng, Feng Huang, Zhaojin Yu, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1566-1582.e10
Open Access | Times Cited: 156
The roles and implications of RNA m6A modification in cancer
Xiaolan Deng, Ying Qing, David Horne, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 507-526
Closed Access | Times Cited: 136
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 131
FTO in cancer: functions, molecular mechanisms, and therapeutic implications
Yangchan Li, Rui Su, Xiaolan Deng, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 598-614
Open Access | Times Cited: 118
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma
Ruichao Chai, Yuzhou Chang, Xin Chang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 115
Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2‐dependent silencing of SLC7A11
Zhuoyang Fan, Guowei Yang, Wei Zhang, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 21, pp. 10197-10212
Open Access | Times Cited: 111
Moonlighting functions of metabolic enzymes and metabolites in cancer
Chaoyun Pan, Bo Li, M. Celeste Simon
Molecular Cell (2021) Vol. 81, Iss. 18, pp. 3760-3774
Open Access | Times Cited: 98
The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability
Nan Zhang, Yan Shen, Huan Li, et al.
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 2, pp. 194-205
Open Access | Times Cited: 80
FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner
Feihong Ji, Xing-Hao Fu, Guoquan Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 74
RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer
Wei Li, Xiaolan Deng, Jianjun Chen
Seminars in Cancer Biology (2022) Vol. 86, pp. 664-677
Open Access | Times Cited: 73
Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
Tongxin Ge, Xiang Gu, Renbing Jia, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1049-1082
Open Access | Times Cited: 72
METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism
Li Han, Lei Dong, Keith Leung, et al.
Cell stem cell (2023) Vol. 30, Iss. 1, pp. 52-68.e13
Open Access | Times Cited: 72
NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression
Hao Zhang, Xiangyu Zhai, Yanfeng Liu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 50
m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion
Xiaoxue Cao, Qishun Geng, Danping Fan, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 46
Lactylation-Related Gene Signature Effectively Predicts Prognosis and Treatment Responsiveness in Hepatocellular Carcinoma
Zhe Cheng, Huichao Huang, Maoyu Li, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 644-644
Open Access | Times Cited: 46
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis
Shimeng Zhou, Junlan Liu, Andi Wan, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 19
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 12
N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer
Senxu Lu, Li Han, Xiao Hu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 85
m6A Methylation Regulates Osteoblastic Differentiation and Bone Remodeling
Mei Huang, Shaozhe Xu, Li-Fei Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 76
RNA m 1 A methylation regulates glycolysis of cancer cells through modulating ATP5D
Yingmin Wu, Zhuojia Chen, Guoyou Xie, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 28
Open Access | Times Cited: 60
N6-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming
Kun Zhang, Tao Zhang, Yuhan Yang, et al.
Theranostics (2022) Vol. 12, Iss. 10, pp. 4802-4817
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top